1. Pricing and Market Access Challenges in the Era of One-Time Administration Cell and Gene Therapies

   • Marco T. Sabatini
   • Tia Xia
   • Mark Chalmers

   Current Opinion 22 August 2022 Pages: 265 - 274

   

2. Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK

   • Rajmeet Jandu
   • Carl Naraynassamy
   • Nadarajah Sreeharan

   Current Opinion 28 July 2022 Pages: 275 - 278

3. Medical Research Charities and Biopharmaceutical Companies as Partners in Patient-Centred R&D

   • Tina Flatau
   • Julie Greenfield
   • John Wise

   Current Opinion 12 August 2022 Pages: 279 - 286

4. The Randomised Controlled Trial at the Intersection of Research Ethics and Innovation

   • Torbjörn Callréus

   Leading Article 25 July 2022 Pages: 287 - 293

5. The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature

   • Maribel Salas
   • Jan Petracek
   • Tina Bostic

   Systematic Review 29 July 2022 Pages: 295 - 306

   

6. Utilizing Deep Learning for Detecting Adverse Drug Events in Structured and Unstructured Regulatory Drug Data Sets

   • Benjamin M. Knisely
   • Qais Hatim
   • Monifa Vaughn-Cooke

   Original Research Article 24 July 2022 Pages: 307 - 317

   

7. Major Pharmaceutical Conferences and Courses: December 2022 to January 2023

   Update 12 September 2022 Pages: 319 - 321